Expert Insights
ETF Channels
ETF Strategist
Exchange – An ETF Experience
Multi-Asset
Smart Beta
Beyond Basic Beta
Thematic Investing
Leveraged & Inverse
Disruptive Technology
Innovative ETFs
Equity ETF
Retirement ETF
Crypto
ETF Building Blocks
Nasdaq Investment Intelligence
Model Portfolio
Active ETF
ESG
Multi-Factor
Entrepreneur ETF
ETF 360
ETF Education
Gold & Silver Investing
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA – iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX – VanEck Vectors Gold Miners ETF
XLF – Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV – Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
ETF Education
Newsletter
New ETFs
ETF Ecosystem
Education Central
Video
Podcasts
ETF Playbook
Virtual Summits
ETFs Future-Forward 2021: An iShares Investing Symposium
Three Themes for 2021: An iShares & MSCI Investing Symposium
BBH
Featured
Biogen Boosts Biotech ETFs to More New Highs
By
Todd Shriber
March 20, 2015
Featured
ETFs for the Next Biotech Takeover Targets
By
Todd Shriber
March 10, 2015
Featured
A Biotech ETF Right for Oncology Mergers and Acquisitions
By
Todd Shriber
March 9, 2015
Featured
Healthcare ETFs up at Least 10% This Year
By
Tom Lydon
February 26, 2015
Featured
Healthcare ETFs Have More Room to Run
By
Tom Lydon
February 11, 2015
Featured
Gilead Could Goose Biotech ETFs
By
Todd Shriber
February 4, 2015
Featured
‘Tis the Season for Biotech ETFs
By
Todd Shriber
January 5, 2015
Featured
The Dominance of Health Care ETFs in One Chart
By
Todd Shriber
November 20, 2014
Featured
Biotech ETFs Prescribe New ETFs
By
Todd Shriber
October 23, 2014
Featured
Biotech ETFs Aren’t Waving the White Flag…Yet
By
Tom Lydon
October 15, 2014
Featured
Biotech ETFs Look to Build on Hot August Returns
By
Tom Lydon
September 3, 2014
Featured
So Much for That Biotech ETF Bubble
By
Todd Shriber
August 20, 2014
Equity ETFs
Most Searched ETFs: Tactical Time
By
Todd Shriber
June 28, 2014
Featured
Vertex Lifts These Biotech ETFs
By
Todd Shriber
June 24, 2014
Featured
More Upside Possible for Biotech ETF
By
Todd Shriber
May 6, 2014
Featured
Biotech ETFs in Bear Market, Plunge Below Key Trendlines
By
Tom Lydon
April 15, 2014
Featured
Investors Say Bye-Bye to Biotech ETFs
By
Todd Shriber
April 8, 2014
Featured
ETF Performance Report: March & Q1
By
Max Chen
March 31, 2014
Previous
1
2
3
4
5
6
7
Next
X